Journals / İstanbul Journal of Pharmacy / 2021 / Cilt: 51 - Sayı: 3

Evaluation of the adherence to antidiabetic medications among Iraqi patients with T2DM using the Iraqi antidiabetic medication adherence scale (IADMAS)

Pages
307–312
Publication Date
2021-12-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The use of IADMAS in this study failed to confirm the consistency between the apparent claims of adherence to anti-diabetic medications and the HbA1c value as a marker of glycemic control.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Aims: Management of diabetes is a multifactorial process, and adherence to treatment programs plays a role in glycemic control.
📊
Key Findings & Data:The present study evaluates the adherence rate to the antidiabetic medications with a newly developed scale and patients’ HbA1c levels among Iraqi patients with type-2 diabetes.
💡
Conclusion & Impact:Conclusion: The use of IADMAS in this study failed to confirm the consistency between the apparent claims of adherence to anti-diabetic medications and the HbA1c value as a marker of glycemic control.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:T2DM · antidiabetic medications · patient adherence

Abstract

Background and Aims: Management of diabetes is a multifactorial process, and adherence to treatment programs plays a role in glycemic control. The present study evaluates the adherence rate to the antidiabetic medications with a newly developed scale and patients’ HbA1c levels among Iraqi patients with type-2 diabetes. Methods: A cross-sectional study among adult patients receiving diabetic care in public and private healthcare settings within Baghdad City was conducted. The medication adherence was evaluated using the Iraqi Antidiabetic Medication Adherence Scale (IADMAS) to determine the factors associated with non-adherence to anti-diabetic medications. Glycated hemoglobin (HbA1c) levels of the participants were used as an indicator of glycemic status. Results: The outcome measures include the comparison between glycemic status and the claims of antidiabetic medication adherence of patients with T2DM, in addition to the expected benefits to clinical practice. A total of 442 patients with type 2 diabetes participated in the study and responded by completing the given questionnaire (response rate: 96.1%). The prevalence of non-adherence to medication was reported to be no more than 30%. Adherence based on HbA1c values reflected a high false-positive value of adherence with an extremely high true negative value. The adherence of Iraqi patients to their medications demonstrated a high negative predictive value (0.905) and a high sensitivity (0.928) with low specificity (0.156) values. Conclusion: The use of IADMAS in this study failed to confirm the consistency between the apparent claims of adherence to anti-diabetic medications and the HbA1c value as a marker of glycemic control.

🔖

Cite This Article

HUSSAİN, S. A., AL-TUKMAGİ, H. F., ABDULRAHMAN, Z. S., SADEQ, M. M., HASHİM, D. N., KADHİM, R. S., KUBBA, M. M. M., AL-TUKMAGİ, D. H. (2021). Evaluation of the adherence to antidiabetic medications among Iraqi patients with T2DM using the Iraqi antidiabetic medication adherence scale (IADMAS). İstanbul Journal of Pharmacy, Cilt: 51 - Sayı: 3, 307–312. https://ajindex.com/articles/676231

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Abebe, S. M., Berhane, Y. & Worku, A. (2014). Barriers to diabetes medication adherence in North West Ethiopia. SpringerPlus, 3(1), 195. https://doi:10.1186/2193-1801-3-195 • Ahmad, N. S., Ramli, A., Islahudin, F. & Paraidathathu, T. (2013). Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Preference and Adherence, 7, 525-530. https://doi:10.2147/PPA.S44698 • American Diabetes Association. (2020). Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care, 43(Suppl. 1), S14-S31. https://doi:10.2337/dc20-S002 • Aminde, L. N., Tindong, M., Ngwasiri, C. A., Aminde, J. A., Njim, T., Fondong, A. A., & Takah, N. F. (2019). Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. BMC Endocrine Disorders, 19(1), 35. https:// doi:10.1186/s12902-019-0360-9 • Bagonza, J., Rutebemberwa, E. & Bazeyo, W. (2015). Adherence to anti-diabetic medication among patients with diabetes in eastern Uganda; a cross sectional study. BMC Health Services Research, 15(1), 168. https://doi:10.1186/s12913-015-0820-5 • Bertoni, A. G., Krop, J. S., Anderson, G. F. & Brancati, F. L. (2002). Diabetes-related morbidity and mortality in a national sample of U.S. elders. Diabetes Care, 25(3), 471-475. https://doi:10.2337/diacare. 25.3.471 • Bi, Y., Wang, T., Xu, M., Xu, Y., Li, M., Lu, J. …Ning, G. (2012). Advanced research on risk factors of type 2 diabetes. Diabetes Metabolism Research and Reviews, 28(Suppl. 2), 32-39. https:// doi:10.1002/dmrr.2352 • Capoccia, K., Odegard, P. S. & Letassy, N. (2016). Medication adherence with diabetes medication: a systematic review of the literature. The Diabetes Educator, 42(1), 34-71. https:// doi:10.1177/0145721715619038 • Chan, M. (2017). Obesity and diabetes: the slow-motion disaster. Milbank Quarterly, 95(1), 11-14. https://doi:10.1111/1468-0009.12238 • Chaudhury, A., Duvoor, C., Reddy Dendi, V. S., Kraleti, S., Chada, A., Ravilla, R. …Mirza, W. (2017). Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management. Frontiers in Endocrinology, 8, 6. https://doi:10.3389/fendo.2017.00006 • Chia, L. R., Schlenk, E. A. & Dunbar-Jacob, J. (2006). Effect of personal and cultural beliefs on medication adherence in the elderly. Drugs & Aging, 23(3), 191-202. https://doi:10.2165/00002512-200623030- 00002 • Chung, W.